Cargando…
Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma
The human placenta shares properties with solid tumors, such as rapid growth, tissue invasion, cell migration, angiogenesis, and immune evasion. However, the mechanisms that drive the evolution from premalignant proliferative placental diseases—called hydatidiform moles—to their malignant counterpar...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533618/ https://www.ncbi.nlm.nih.gov/pubmed/34680590 http://dx.doi.org/10.3390/biomedicines9101474 |
_version_ | 1784587357230465024 |
---|---|
author | Collet, Constance Lopez, Jonathan Battail, Christophe Allias, Fabienne Devouassoux-Shisheboran, Mojgan Patrier, Sophie Lemaitre, Nicolas Hajri, Touria Massardier, Jérôme You, Benoit Mallet, François Golfier, François Alfaidy, Nadia Bolze, Pierre-Adrien |
author_facet | Collet, Constance Lopez, Jonathan Battail, Christophe Allias, Fabienne Devouassoux-Shisheboran, Mojgan Patrier, Sophie Lemaitre, Nicolas Hajri, Touria Massardier, Jérôme You, Benoit Mallet, François Golfier, François Alfaidy, Nadia Bolze, Pierre-Adrien |
author_sort | Collet, Constance |
collection | PubMed |
description | The human placenta shares properties with solid tumors, such as rapid growth, tissue invasion, cell migration, angiogenesis, and immune evasion. However, the mechanisms that drive the evolution from premalignant proliferative placental diseases—called hydatidiform moles—to their malignant counterparts, gestational choriocarcinoma, as well as the factors underlying the increased aggressiveness of choriocarcinoma arising after term delivery compared to those developing from hydatidiform moles, are unknown. Using a 730-gene panel covering 13 cancer-associated canonical pathways, we compared the transcriptomic profiles of complete moles to those of postmolar choriocarcinoma samples and those of postmolar to post-term delivery choriocarcinoma. We identified 33 genes differentially expressed between complete moles and postmolar choriocarcinoma, which revealed TGF-β pathway dysregulation. We found the strong expression of SALL4, an upstream regulator of TGF-β, in postmolar choriocarcinoma, compared to moles, in which its expression was almost null. Finally, there were no differentially expressed genes between postmolar and post-term delivery choriocarcinoma samples. To conclude, the TGF-β pathway appears to be a crucial step in the progression of placental malignancies. Further studies should investigate the value of TGF- β family members as biomarkers and new therapeutic targets. |
format | Online Article Text |
id | pubmed-8533618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85336182021-10-23 Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma Collet, Constance Lopez, Jonathan Battail, Christophe Allias, Fabienne Devouassoux-Shisheboran, Mojgan Patrier, Sophie Lemaitre, Nicolas Hajri, Touria Massardier, Jérôme You, Benoit Mallet, François Golfier, François Alfaidy, Nadia Bolze, Pierre-Adrien Biomedicines Article The human placenta shares properties with solid tumors, such as rapid growth, tissue invasion, cell migration, angiogenesis, and immune evasion. However, the mechanisms that drive the evolution from premalignant proliferative placental diseases—called hydatidiform moles—to their malignant counterparts, gestational choriocarcinoma, as well as the factors underlying the increased aggressiveness of choriocarcinoma arising after term delivery compared to those developing from hydatidiform moles, are unknown. Using a 730-gene panel covering 13 cancer-associated canonical pathways, we compared the transcriptomic profiles of complete moles to those of postmolar choriocarcinoma samples and those of postmolar to post-term delivery choriocarcinoma. We identified 33 genes differentially expressed between complete moles and postmolar choriocarcinoma, which revealed TGF-β pathway dysregulation. We found the strong expression of SALL4, an upstream regulator of TGF-β, in postmolar choriocarcinoma, compared to moles, in which its expression was almost null. Finally, there were no differentially expressed genes between postmolar and post-term delivery choriocarcinoma samples. To conclude, the TGF-β pathway appears to be a crucial step in the progression of placental malignancies. Further studies should investigate the value of TGF- β family members as biomarkers and new therapeutic targets. MDPI 2021-10-14 /pmc/articles/PMC8533618/ /pubmed/34680590 http://dx.doi.org/10.3390/biomedicines9101474 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Collet, Constance Lopez, Jonathan Battail, Christophe Allias, Fabienne Devouassoux-Shisheboran, Mojgan Patrier, Sophie Lemaitre, Nicolas Hajri, Touria Massardier, Jérôme You, Benoit Mallet, François Golfier, François Alfaidy, Nadia Bolze, Pierre-Adrien Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title | Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title_full | Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title_fullStr | Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title_full_unstemmed | Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title_short | Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma |
title_sort | transcriptomic characterization of postmolar gestational choriocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533618/ https://www.ncbi.nlm.nih.gov/pubmed/34680590 http://dx.doi.org/10.3390/biomedicines9101474 |
work_keys_str_mv | AT colletconstance transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT lopezjonathan transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT battailchristophe transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT alliasfabienne transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT devouassouxshisheboranmojgan transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT patriersophie transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT lemaitrenicolas transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT hajritouria transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT massardierjerome transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT youbenoit transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT malletfrancois transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT golfierfrancois transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT alfaidynadia transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma AT bolzepierreadrien transcriptomiccharacterizationofpostmolargestationalchoriocarcinoma |